Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EADO 2018 /
Managing uncertainty in Spitz Nevi melanoma

6th - 9th Nov 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.18
Views: 710

Prof Vernon Sondak - H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

Prof Vernon Sondak speaks with ecancer at the EADO 2018 congress in Barcelona about managing the uncertainty of Spitz Nevi melanoma.

Prof Sondak explains that there is a small number of atypical spitz tumours where it is difficult to determine whether it is truly benign or if it is truly cancerous, leading to confusion and uncertainty for patients and doctors.

He details that there are ways to manage the uncertainty and that, if it comes to it, they can treat the worst case scenario, which isn't always as bad as feared.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation